Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
2(14%)
Results Posted
11%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
1
7%
Ph phase_2
1
7%
Ph not_applicable
12
86%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
1(7.1%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(9)
Terminated(1)
Other(1)

Detailed Status

Completed9
Recruiting2
unknown1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
90.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (7.1%)
Phase 21 (7.1%)
N/A12 (85.7%)

Trials by Status

unknown17%
recruiting214%
terminated17%
completed964%
not_yet_recruiting17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14